Adorno M, Cordenonsi M, Montagner M, Dupont S, Wong C, Hann B, Solari A, Bobisse S, Rondina MB, Guzzardo V, et al. A mutant-p53/Smad complex opposes p63 to empower TGFβ-induced metastasis. Cell. 2009;137(1):87–98. https://doi.org/10.1016/j.cell.2009.01.039.

Article  CAS  PubMed  Google Scholar 

Bae D-S, Blazanin N, Licata M, Lee J, Glick AB. Tumor suppressor and oncogene actions of TGFβ1 occur early in skin carcinogenesis and are mediated by Smad3. Mol Carcinog. 2009;48(5):441–53. https://doi.org/10.1002/mc.20482.

Article  CAS  PubMed  Google Scholar 

Balzeau J, Menezes MR, Cao S, Hagan JP. The LIN28/let-7 Pathway in Cancer. Front. Genet. 2017 [accessed 2023 Jul 23];8. https://doi.org/10.3389/fgene.2017.00031/full. https://doi.org/10.3389/fgene.2017.00031

Bedi A, Chang X, Noonan K, Pham V, Bedi R, Fertig EJ, Considine M, Califano JA, Borrello I, Chung CH, et al. Inhibition of TGF-β enhances the in vivo antitumor efficacy of EGF receptor-targeted therapy. Mol Cancer Ther. 2012;11(11):2429–39. https://doi.org/10.1158/1535-7163.MCT-12-0101-T.

Article  CAS  PubMed  Google Scholar 

Berraondo P, Sanmamed MF, Ochoa MC, Etxeberria I, Aznar MA, Pérez-Gracia JL, Rodríguez-Ruiz ME, Ponz-Sarvise M, Castañón E, Melero I. Cytokines in clinical cancer immunotherapy. Br J Cancer. 2019;120(1):6–15. https://doi.org/10.1038/s41416-018-0328-y.

Article  CAS  PubMed  Google Scholar 

Bhattacharjee B, Syeda AF, Rynjah D, Hussain SM, Chandra Bora S, Pegu P, Sahu RK, Khan J. Pharmacological impact of microRNAs in head and neck squamous cell carcinoma: prevailing insights on molecular pathways, diagnosis, and nanomedicine treatment. Front Pharmacol. 2023;14:1174330. https://doi.org/10.3389/fphar.2023.1174330.

Article  CAS  PubMed  Google Scholar 

Bissey P-A, Teng M, Law JH, Shi W, Bruce JP, Petit V, Tsao SW, Yip KW, Liu F-F. MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma. BMC Cancer. 2020;20(1):597. https://doi.org/10.1186/s12885-020-07081-z.

Article  CAS  PubMed  Google Scholar 

Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, et al. Radiotherapy plus Cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006;354(6):567–78. https://doi.org/10.1056/NEJMoa053422.

Article  CAS  PubMed  Google Scholar 

Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6(11):857–66. https://doi.org/10.1038/nrc1997.

Article  CAS  PubMed  Google Scholar 

Carbone M, Amelio I, Affar EB, Brugarolas J, Cannon-Albright LA, Cantley LC, Cavenee WK, Chen Z, Croce CM, Andrea AD, et al. Consensus report of the 8 and 9th Weinman Symposia on Gene x Environment Interaction in carcinogenesis: novel opportunities for precision medicine. Cell Death Differ. 2018;25(11):1885–904. https://doi.org/10.1038/s41418-018-0213-5.

Article  PubMed  Google Scholar 

Chang H, Brown CW, Matzuk MM. Genetic analysis of the mammalian transforming growth factor-β superfamily. Endocr Rev. 2002;23(6):787–823. https://doi.org/10.1210/er.2002-0003.

Article  CAS  PubMed  Google Scholar 

Chen L, Sun D-Z, Fu Y-G, Yang P-Z, Lv H-Q, Gao Y, Zhang X-Y. Upregulation of microRNA-141 suppresses epithelial-mesenchymal transition and lymph node metastasis in laryngeal cancer through HOXC6-dependent TGF-β signaling pathway. Cellular Signal. 2020;66: 109444. https://doi.org/10.1016/j.cellsig.2019.109444.

Article  CAS  Google Scholar 

Chen L, Zhu Q, Lu L, Liu Y. MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1. Bioengineered. 2020;11(1):91–102. https://doi.org/10.1080/21655979.2019.1710925.

Article  CAS  PubMed  Google Scholar 

Chen S, Zhang J, Sun L, Li X, Bai J-Y, Zhang H, Li T. miR-762 promotes malignant development of head and neck squamous cell carcinoma by targeting PHLPP2 and FOXO4. Onco Targets Ther. 2019;12:11425–36. https://doi.org/10.2147/OTT.S221442.

Article  CAS  PubMed  Google Scholar 

Cheng CM, Shiah SG, Huang CC, Hsiao JR, Chang JY. Up-regulation of miR-455-5p by the TGF-β-SMAD signalling axis promotes the proliferation of oral squamous cancer cells by targeting UBE2B: MiR-455-5p regulates oral cancer cell proliferation through UBE2B. J Pathol. 2016;240(1):38–49. https://doi.org/10.1002/path.4752.

Article  CAS  PubMed  Google Scholar 

Chikuda J, Otsuka K, Shimomura I, Ito K, Miyazaki H, Takahashi R, Nagasaki M, Mukudai Y, Ochiya T, Shimane T, et al. CD44s induces miR-629-3p expression in association with cisplatin resistance in head and neck cancer cells. Cancers. 2020;12(4):856. https://doi.org/10.3390/cancers12040856.

Article  CAS  PubMed  Google Scholar 

Christensen BC, Moyer BJ, Avissar M, Ouellet LG, Plaza SL, McClean MD, Marsit CJ, Kelsey KT. A let-7 microRNA-binding site polymorphism in the KRAS 3’ UTR is associated with reduced survival in oral cancers. Carcinogenesis. 2009;30(6):1003–7. https://doi.org/10.1093/carcin/bgp099.

Article  CAS  PubMed  Google Scholar 

Chu T-H, Yang C-C, Liu C-J, Lui M-T, Lin S-C, Chang K-W. miR-211 promotes the progression of head and neck carcinomas by targeting TGFβRII. Cancer Lett. 2013;337(1):115–24. https://doi.org/10.1016/j.canlet.2013.05.032.

Article  CAS  PubMed  Google Scholar 

Chu YH, Tzeng SL, Lin CW, Chien MH, Chen MK, Yang SF. Impacts of MicroRNA Gene Polymorphisms on the Susceptibility of Environmental Factors Leading to Carcinogenesis in Oral Cancer. Christensen BC, editor. PLoS ONE. 2012;7(6):e39777. https://doi.org/10.1371/journal.pone.0039777

Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A. 2005;102(39):13944–9. https://doi.org/10.1073/pnas.0506654102.

Article  CAS  PubMed  Google Scholar 

Cui W, Meng W, Zhao L, Cao H, Chi W, Wang B. TGF-β-induced long non-coding RNA MIR155HG promotes the progression and EMT of laryngeal squamous cell carcinoma by regulating the miR-155–5p/SOX10 axis. Int J Oncol. 2019 Apr 12 [accessed 2023 Mar 25].https://doi.org/10.3892/ijo.2019.4784. https://doi.org/10.3892/ijo.2019.4784

Douglas WG, Tracy E, Tan D, Yu J, Hicks WL, Rigual NR, Loree TR, Wang Y, Baumann H. Development of head and neck squamous cell carcinoma is associated with altered cytokine responsiveness. Mol Cancer Res. 2004;2(10):585–93.

Article  CAS  PubMed  Google Scholar 

Expósito-Villén A, Aránega E, Franco D. Functional role of non-coding RNAs during epithelial-to-mesenchymal transition. NonCoding RNA. 2018;4(2):14. https://doi.org/10.3390/ncrna4020014.

Article  CAS  PubMed  Google Scholar 

Falco M, Tammaro C, Takeuchi T, Cossu AM, Scafuro G, Zappavigna S, Itro A, Addeo R, Scrima M, Lombardi A, et al. Overview on molecular biomarkers for laryngeal cancer: looking for new answers to an old problem. Cancers. 2022;14(7):1716. https://doi.org/10.3390/cancers14071716.

Article  CAS  PubMed  Google Scholar 

Freudlsperger C, Bian Y, Contag Wise S, Burnett J, Coupar J, Yang X, Chen Z, Van Waes C. TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers. Oncogene. 2013;32(12):1549–59. https://doi.org/10.1038/onc.2012.171.

Article  CAS  PubMed  Google Scholar 

Frixa T, Donzelli S, Blandino G. Oncogenic MicroRNAs: key players in malignant transformation. Cancers. 2015;7(4):2466–85. https://doi.org/10.3390/cancers7040904.

Article  CAS  PubMed  Google Scholar 

Gao W, Zhang C, Li W, Li H, Sang J, Zhao Q, Bo Y, Luo H, Zheng X, Lu Y, et al. Promoter methylation-regulated miR-145-5p inhibits laryngeal squamous cell carcinoma progression by targeting FSCN1. Mol Ther. 2019;27(2):365–79. https://doi.org/10.1016/j.ymthe.2018.09.018.

Article  CAS  PubMed  Google Scholar 

Garzon R, Calin GA, Croce CM. MicroRNAs in cancer. Annu Rev Pathol Mech Dis. 2009;60(1):167–79. https://doi.org/10.1146/annurev.med.59.053006.104707.

Article  CAS  Google Scholar 

Garzon R, Marcucci G, Croce CM. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov. 2010;9(10):775–89. https://doi.org/10.1038/nrd3179.

Article  CAS